In focus · trending topic

Nuvaira AIRFLOW-2 trial

1 stories · following the connections

Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD

By Nasdaq OMXJun 27, 2017, 1:00 PM UTC